![Rolf Stahel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 31 297 $ al 31/07/2026
Rolf Stahel is the founder and the Executive Chairman of Chesyl Pharma Ltd., which was founded in 1994.
He is also the Non-Executive Chairman of Ampha Ltd., starting in 2016.
Mr. Stahel's former positions include being the Chief Executive Officer of Shire Pharmaceuticals, Inc. from 1994 to 2003, the Non-Executive Chairman of EUSA Pharma, Inc., the Chairman of Cosmo Pharmaceuticals SA from 2006 to 2010, the Non-Executive Chairman of PowderMed Ltd. in 2006, the Non-Executive Chairman of Newron Pharmaceuticals SpA from 2012 to 2013, the Deputy Chairman of Cosmo Holding SpA in 2007, the Non-Executive Chairman of Connexios Life Sciences Pvt Ltd. from 2009 to 2016, the Non-Executive Chairman of Ergomed Plc from 2014 to 2017, the Non-Executive Chairman of Biodexa Pharmaceuticals Plc from 2014 to 2022, and the Director-Group Marketing of Wellcome Plc from 1967 to 1994.
Mr. Stahel's education includes an undergraduate degree from Kantons-schule.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Hargreave Hale AIM VCT
 Hargreave Hale AIM VCT Investment ManagersFinance Functions as a private equity fund 0,02 % | 05/06/2026 | 76.000 ( 0,02 % ) | 31 297 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Ampha Ltd.
 Ampha Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Presidente | 01/12/2016 |
| Empresas | Cargo | Fin |
|---|---|---|
Chesyl Pharma Ltd. | Fundador | 26/08/2024 |
| BIODEXA PHARMACEUTICALS PLC | Presidente | 20/06/2022 |
| ERGOMED | Presidente | 01/03/2017 |
Connexios Life Sciences Pvt Ltd.
 Connexios Life Sciences Pvt Ltd. Pharmaceuticals: GenericHealth Technology Discovers and develops small molecule therapeutics | Presidente | 01/01/2016 |
| NEWRON PHARMACEUTICALS S.P.A. | Presidente | 18/04/2013 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 13 |
|---|---|
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
Cosmo Pharmaceuticals SA
 Cosmo Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company | Health Technology |
Wellcome Plc
 Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Operates as a charitable foundation for healthcare | Commercial Services |
PowderMed Ltd.
 PowderMed Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic products | Health Technology |
Newron Pharmaceuticals SpA
 Newron Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and sells novel therapies central & peripheral nervous system | Health Technology |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Chesyl Pharma Ltd. | |
Connexios Life Sciences Pvt Ltd.
Connexios Life Sciences Pvt Ltd. Pharmaceuticals: GenericHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Kantons-schule
 Kantons-schule Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ergomed Plc
 Ergomed Plc BiotechnologyHealth Technology Engages in research and development of drugs for oncology & rare diseases | Health Technology |
Biodexa Pharmaceuticals Plc
 Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Ampha Ltd.
Ampha Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
